Viatris tops quarterly estimates on strong China growth
The drugmaker reported first-quarter revenue of 3.52 billion dollars and adjusted profit of 59 cents per share. Growth was driven by strong demand in China.
Xurve View
Insights:
Xurve View
VIATRIS INC reported first-quarter revenue of $3.52 billion and adjusted profit of 59 cents per share, beating estimates of $3.36 billion and 50 cents. Shares rose 3% in afternoon trading following the results, which showed revenue growth of 8% from a year ago. Strong demand in China and branded drug sales are stabilizing the base business against manufacturing and generic competition pressures.
